Patient-reported outcomes with durvalumab after chemoradiotherapy in stage III, unresectable non-small-cell lung cancer (PACIFIC): a randomised, controlled, phase 3 study by Hui, Rina, Prof, Özgüroğlu, Mustafa, Prof, Villegas, Augusto, MD, Daniel, Davey, MD, Vicente, David, MD, Murakami, Shuji, MD, Yokoi, Takashi, MD, Chiappori, Alberto, MD, Lee, Ki Hyeong, MD, de Wit, Maike, Prof, Cho, Byoung Chul, Prof, Gray, Jhanelle E, MD, Rydén, Anna, PhD, Viviers, Louis, MD, Poole, Lynne, MSc, Zhang, Yiduo, PhD, Dennis, Phillip A, MD, Antonia, Scott J, MD

Get full text